Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, December 26, 2024.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Weak Uptrend (+65) - BCRX is showing signs of weakening momentum to the upside. Monitor BCRX as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid BCRX?
MarketClub looks at technical strength and momentum to determine if the timing is right for BCRX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for BCRX
The long-term trend has been UP since May 15th, 2024 at 6.35
The intermediate-term trend has been DOWN since Nov 4th, 2024 at 7.24
The short-term trend has been UP since Dec 23rd, 2024 at 7.60
Smart Scan Analysis for BCRX
Based on our trend formula, BCRX is rated as a +65 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 7.650 | 7.830 | 7.620 | 7.745 | +0.075 |
| Prev. Close | Volume | Bid | Ask | Time |
| 7.670 | 778392 | 2024-12-26 14:58:09 |
| Year High | 9.705 | Year High Date | 2018-11-23 |
| Year Low | 4.25 | Year Low Date | 2018-02-05 |
| 52wk High | 8.88 | 52wk High Date | 2024-09-03 |
| 52wk Low | 4.03 | 52wk Low Date | 2024-04-25 |
| Year End Close | 1.42 | Average Volume | 1,821,400 |
| Shares Outstanding | 206,886 | Short Interest | 3,767,227 |
| % Institutional | 37.1 | Market Cap | 363M |
| Assets | 491,254,000M | Liabilities | 959,817,000M |
| Beta | 1.96 | Volatility | 69.96 |